Required for Advisory Committee for Borderline Substances (ACBS) approval. Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus to show that it is acceptable for patients in the United Kingdom.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
23
Oral nutritional supplementation
Sheffield Teaching Hospitals NHS Foundation Trust, The Royal Hallamshire Hospital, Regional Gastrointestinal and Liver Unit
Sheffield, United Kingdom
Occurrence of gastrointestinal tolerance parameters (Diarrhoea, Constipation, Bloating, Distension, Nausea, Vomiting, Burping, Regurgitation, Flatulence, Abdominal discomfort, Abdominal pain, Other (further gastrointestinal adverse events)
Parameters asked as required for acceptability studies by Advisory Committee for Borderline Substances- documented in a patient diary
Time frame: 7 days
Occurrence of further adverse effects
Time frame: 7 days
Evaluation of palatability by questionnaire
Five point hedonic scale
Time frame: 1 day
Evaluation of compliance.
Comparison of prescription and actual intake
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.